About 1 Trademarks found for “RAYLUMI”

Pharmaceutical preparations for the prevention and treatment of psychiatric diseases, degenerative nerve diseases and brain disorders, namely, mood, anxiety and cognitive disorders, Alzheimer's disease, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis, none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs); Pharmaceutical preparations for the prevention and treatment of cranial and facial nerve disorders, connective tissue injuries, diseases and disorders, bone and cartilage injuries, diseases and disorders, none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs); Pharmaceutical preparations for the prevention and treatment of neuromuscular and neurological diseases and disorders, namely, central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, muscle diseases and disorders, namely inflammatory muscle diseases and disorders and muscular dystrophy, ocular motility and spinal cord infections, injuries and diseases, and seizure disorders, none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs); Pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, inflammatory pelvic, vaginitis, dysmenorrhea, cervix erosion, cervicitis, trachelitis, uterine cervicitis, endomitriosis, sexually transmitted diseases, erectile and sexual dysfunction, infertility and incontinence, none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs); Pharmaceutical preparations for the prevention and treatment of cardiovascular, gastrointestinal, blood, oncological, ophthalmological and respiratory system diseases and disorders, none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs); Pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders, namely collagen disease, rheumatoid arthritis, systemic lupus erythematosus, alopecia areata, and systemic sclerosis, none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs); Pharmaceutical preparations for the prevention and treatment of allergies, hypertension, menopause, diabetic neuropathy, arthritis, and pain, none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs); Antibiotics, anti-infectives, anti-inflammatories, anti-fungals, anti-virals, oral and injectable pharmaceutical contraceptives, human vaccines, none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs); Pharmaceutical preparations for the prevention and treatment of smoking habits and addictions, none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs); Pharmaceutical preparations for the prevention and treatment of renal disease and disorders, none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs); Pharmaceutical preparations for the prevention and treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs); Pharmaceutical preparations for the prevention and treatment of muscular atrophy, none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs); Pharmaceutical preparations for the prevention and treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders, none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs); Pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, hypoglycemia, muscular dystrophy, sickle cell disease, non-alcoholic steatohepatitis and anemia, none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs); Pharmaceutical preparations for the prevention and treatment of dermatological diseases and conditions, namely eczema, atopic dermatitis, psoriasis, bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, acne, pyoderma, erosion, ulcer, trauma, burned skin, pain and inflammation, none of the aforementioned for use in embolization, the treatment of circulatory system conditions or the treatment of tumors and arteriovenous malformations (AVMs).